Abbott Laboratories (ABT) EBITDA Margin (2009 - 2026)
Abbott Laboratories recorded quarterly EBITDA Margin of 12.05% in Q1 2026, down 38.67% quarter-over-quarter from 19.64% in Q4 2025, and down 430.0% year-over-year from 3.65% in Q1 2025.
Abbott Laboratories' EBITDA Margin history runs 18 years deep, the most recent figure standing at 12.05% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 430.0% year-over-year to 12.05%; the TTM figure through Mar 2026 stood at 17.07% (up 23.0% YoY), while the FY2025 annual figure was 18.17%, up 190.0% from the prior year.
- EBITDA Margin came in at 12.05% for Q1 2026 at Abbott Laboratories, down from 19.64% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 24.48% in Q1 2022 to a low of 12.05% in Q1 2026.
- A 5-year average of 17.03% and a median of 17.0% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 749 bps in 2022 and sank 900 bps in 2023, its largest moves.
- Abbott Laboratories' EBITDA Margin stood at 12.92% in 2022, then surged by 35 bps to 17.38% in 2023, then grew by 0 bps to 17.41% in 2024, then advanced by 13 bps to 19.64% in 2025, then sank by 39 bps to 12.05% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 12.05%, 19.64%, and 18.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.05% |
| Dec 31, 2025 | 19.64% |
| Sep 30, 2025 | 18.09% |
| Jun 30, 2025 | 18.42% |
| Mar 31, 2025 | 16.34% |
| Dec 31, 2024 | 17.41% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | 16.08% |
| Mar 31, 2024 | 13.91% |
| Dec 31, 2023 | 17.38% |
| Sep 30, 2023 | 16.24% |
| Jun 30, 2023 | 15.45% |
| Mar 31, 2023 | 15.48% |
| Dec 31, 2022 | 12.92% |
| Sep 30, 2022 | 17.00% |
| Jun 30, 2022 | 21.11% |
| Mar 31, 2022 | 24.48% |
| Dec 31, 2021 | 20.74% |
| Sep 30, 2021 | 23.30% |
| Jun 30, 2021 | 13.62% |
| Mar 31, 2021 | 20.17% |
| Dec 31, 2020 | 22.73% |
| Sep 30, 2020 | 16.89% |
| Jun 30, 2020 | 9.17% |
| Mar 31, 2020 | 9.81% |
| Dec 31, 2019 | 16.71% |
| Sep 30, 2019 | 14.83% |
| Jun 30, 2019 | 15.11% |
| Mar 31, 2019 | 9.81% |
| Dec 31, 2018 | 15.00% |
| Sep 30, 2018 | 13.00% |
| Jun 30, 2018 | 11.36% |
| Mar 31, 2018 | 8.23% |
| Dec 31, 2017 | 8.58% |
| Sep 30, 2017 | 11.26% |
| Jun 30, 2017 | 5.82% |
| Mar 31, 2017 | -3.82% |
| Dec 31, 2016 | 14.79% |
| Sep 30, 2016 | 16.92% |
| Jun 30, 2016 | 15.30% |
| Mar 31, 2016 | 10.73% |
| Dec 31, 2015 | 15.71% |
| Sep 30, 2015 | 13.84% |
| Jun 30, 2015 | 14.10% |
| Mar 31, 2015 | 12.46% |
| Dec 31, 2014 | 15.48% |
| Sep 30, 2014 | 14.33% |
| Jun 30, 2014 | 13.39% |
| Mar 31, 2014 | 7.68% |
| Dec 31, 2013 | 12.38% |
| Sep 30, 2013 | 9.84% |
| Jun 30, 2013 | 12.71% |
| Mar 31, 2013 | 12.69% |
| Dec 31, 2012 | -0.42% |
| Sep 30, 2012 | 5.89% |
| Jun 30, 2012 | 10.62% |
| Mar 31, 2012 | 9.64% |
| Dec 31, 2011 | -19.66% |
| Sep 30, 2011 | 6.06% |
| Jun 30, 2011 | 18.44% |
| Mar 31, 2011 | 14.39% |
| Dec 31, 2010 | 18.36% |
| Sep 30, 2010 | 13.62% |
| Jun 30, 2010 | 18.20% |
| Mar 31, 2010 | 19.10% |
| Dec 31, 2009 | 21.20% |
| Sep 30, 2009 | 21.13% |
| Jun 30, 2009 | 22.30% |